Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage

Russel J. Reiter, Dun Xian Tan, Eloisa Gitto, Rosa M. Sainz, Juan C. Mayo, Josefa Leon, Lucien C. Manchester, A. Vijayalaxmi, Ertugrul Kilic, Ülkan Kilic

Research output: Contribution to journalReview articlepeer-review

182 Scopus citations


This review briefly summarizes the actions of melatonin in reducing molecular damage caused by free radicals and associated oxygen- and nitrogen-based reactants. All the mechanisms by which melatonin is protective of such a wide variety of molecules, i.e. lipids, proteins, DNA, etc., and in such widely diverse areas of the cell and different organs are likely not yet all identified. Melatonin actions that have been identified include its ability to directly neutralize a number of toxic reactants and stimulate antioxidative enzymes. Furthermore, several metabolites that are formed when melatonin neutralizes damaging reactants are themselves scavengers suggesting that there is a cascade of reactions that greatly increase the efficacy of melatonin in stymying oxidative mutilation. Suggested, but less well defined, processes which may contribute to melatonin's ability to reduce oxidative stress include stimulation of glutathione synthesis (an important antioxidant which is at high concentrations within cells), reducing electron leakage from the mitochondrial electron transport chain (which would reduce free radical generation), limiting cytokine production and inflammatory processes (actions that would also lower toxic reactant generation), and synergistic effects with other classical antioxidants (e.g. vitamins C, E and glutathione). Clearly which of these multiple mechanisms contribute to melatonin's high efficacy in curtailing oxidative damage remains to be clarified. Likewise, it is possible that the key action of melatonin in reducing molecular damage induced by oxygen and nitrogen-based metabolites remains to be identified. Finally, the review summarizes some of the large amount of data documenting the ability of melatonin to limit molecular and organ damage in two situations, i.e. ischemia-reperfusion and ionizing radiation, where free radicals are generally conceded as being responsible for much of the resulting tissue destruction.

Original languageEnglish (US)
Pages (from-to)159-170
Number of pages12
JournalPolish Journal of Pharmacology
Issue number2
StatePublished - 2004


  • Antioxidant
  • Free Radicals
  • Ionizing radiation
  • Ischemia-reperfusion injury
  • Melatonin
  • Oxidative stress

ASJC Scopus subject areas

  • Pharmacology


Dive into the research topics of 'Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage'. Together they form a unique fingerprint.

Cite this